D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 41 Citations 12,179 100 World Ranking 3344 National Ranking 1330

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Virus
  • Immune system

Anthony L. DeVico mainly investigates Virology, Molecular biology, Virus, Immunology and Cytokine. The various areas that Anthony L. DeVico examines in his Virology study include Chemokine, Epitope, Antibody and Glycoprotein. His research integrates issues of Cytotoxic T cell, T lymphocyte and CD8 in his study of Chemokine.

His Molecular biology research is multidisciplinary, relying on both Receptor, Affinity chromatography, Gp41 and Edman degradation. His studies in Cytokine integrate themes in fields like β chemokines, Kaposi's sarcoma, Cellular immunity, Replication and Cytotoxicity. Anthony L. DeVico combines subjects such as Signal transduction, CCL5, CXCR4 and Macrophage inflammatory protein with his study of Chemokine receptor CCR5.

His most cited work include:

  • Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells (2706 citations)
  • The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection (482 citations)
  • Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV (464 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Virology, Antibody, Immunology, Chemokine and Virus. His study in Virology is interdisciplinary in nature, drawing from both Epitope, Gp41 and DNA vaccination. His Antibody study integrates concerns from other disciplines, such as Molecular biology, HIV vaccine and Biochemistry.

His studies examine the connections between Immunology and genetics, as well as such issues in Acquired immunodeficiency syndrome, with regards to Viral disease and Immunopathology. His Chemokine research includes elements of T cell, Chemotaxis and CD8. Anthony L. DeVico has researched Virus in several fields, including Cellular immunity and Cell culture.

He most often published in these fields:

  • Virology (57.36%)
  • Antibody (31.78%)
  • Immunology (28.68%)

What were the highlights of his more recent work (between 2013-2021)?

  • Virology (57.36%)
  • Antibody (31.78%)
  • Antibody-dependent cell-mediated cytotoxicity (6.20%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Virology, Antibody, Antibody-dependent cell-mediated cytotoxicity, Epitope and Immunology. His research in Virology is mostly concerned with Virus. Anthony L. DeVico has included themes like Anti hiv, Affinity chromatography, Biochemistry and Antigen in his Antibody study.

His Antibody-dependent cell-mediated cytotoxicity research integrates issues from Cell-mediated cytotoxicity, Cancer research and Effector. As a member of one scientific family, Anthony L. DeVico mostly works in the field of Effector, focusing on Cytometry and, on occasion, Cytotoxic T cell. His work on Gp41 as part of general Epitope study is frequently linked to Human plasma, bridging the gap between disciplines.

Between 2013 and 2021, his most popular works were:

  • Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection (93 citations)
  • Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates (40 citations)
  • Inhibition of HIV-1 Infection by the b-Chemokine MDC (31 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Immune system

His primary scientific interests are in Antibody, Virology, Epitope, Antibody-dependent cell-mediated cytotoxicity and Effector. His work deals with themes such as Isoelectric focusing, Affinity chromatography and Peptide sequence, which intersect with Antibody. His research is interdisciplinary, bridging the disciplines of Immunology and Virology.

His research investigates the link between Epitope and topics such as Specific antibody that cross with problems in Immunoglobulin G. In his study, Cytotoxic T cell is strongly linked to Monocyte, which falls under the umbrella field of Antibody-dependent cell-mediated cytotoxicity. His research in Cytotoxic T cell intersects with topics in Chemokine, Secretion and CD8.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

Fiorenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Suresh K. Arya.
Science (1995)

3544 Citations

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)

1662 Citations

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV

F. Di Marzo Veronese;T. D. Copeland;A. L. Devico;Rukhsana Rahman.
Science (1986)

715 Citations

The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection

Florenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Andrea Cara.
Nature Medicine (1996)

640 Citations

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

Fulvia DiMarzo Veronese;Anthony L. DeVico;Terry D. Copeland;Stephen Oroszlan.
Science (1985)

568 Citations

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert.
Journal of Virology (2012)

374 Citations

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.

Bala Chandran Nair;Anthony L. DeVico;Shuji Nakamura;Terry D. Copeland.
Science (1992)

297 Citations

Inhibition of HIV-1 Infection by the β-Chemokine MDC

Ranajit Pal;Alfredo Garzino-Demo;Phillip D. Markham;Jennifer Burns.
Science (1997)

289 Citations

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

H Mitsuya;R F Jarrett;M Matsukura;F Di Marzo Veronese.
Proceedings of the National Academy of Sciences of the United States of America (1987)

250 Citations

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

Timothy Fouts;Karla Godfrey;Kathryn Bobb;David Montefiori.
Proceedings of the National Academy of Sciences of the United States of America (2002)

176 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Anthony L. DeVico

David C. Montefiori

David C. Montefiori

Duke University

Publications: 247

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 186

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 155

Guido Ferrari

Guido Ferrari

Duke University

Publications: 127

Andrés Finzi

Andrés Finzi

University of Montreal

Publications: 108

Nelson L. Michael

Nelson L. Michael

Walter Reed Army Institute of Research

Publications: 107

Peter B. Gilbert

Peter B. Gilbert

Fred Hutchinson Cancer Research Center

Publications: 99

Celia C. LaBranche

Celia C. LaBranche

Duke University

Publications: 90

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 90

Merlin L. Robb

Merlin L. Robb

Walter Reed Army Institute of Research

Publications: 88

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 87

Joseph Sodroski

Joseph Sodroski

Harvard University

Publications: 85

Susan Zolla-Pazner

Susan Zolla-Pazner

Icahn School of Medicine at Mount Sinai

Publications: 84

Hua-Xin Liao

Hua-Xin Liao

Jinan University

Publications: 83

Jerome H. Kim

Jerome H. Kim

Walter Reed Army Institute of Research

Publications: 79

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 72

Trending Scientists

Jerry Tersoff

Jerry Tersoff

IBM (United States)

Duane Dimos

Duane Dimos

The University of Texas at Arlington

Tatsushi Toda

Tatsushi Toda

University of Tokyo

Luiz Antonio Martinelli

Luiz Antonio Martinelli

Universidade de São Paulo

C. Michael Bull

C. Michael Bull

Flinders University

William C. Parks

William C. Parks

Cedars-Sinai Medical Center

Owen P. Ward

Owen P. Ward

University of Waterloo

Kwen-Tay Luh

Kwen-Tay Luh

National Taiwan University

Benoit Guieysse

Benoit Guieysse

Massey University

Nicholas A. Beresford

Nicholas A. Beresford

University of Salford

Jin-Hui Wang

Jin-Hui Wang

Chinese Academy of Sciences

Giuseppina Candore

Giuseppina Candore

University of Palermo

Arthur A.M. Wilde

Arthur A.M. Wilde

University of Amsterdam

Dan G. Duda

Dan G. Duda

Harvard University

Marwan N. Sabbagh

Marwan N. Sabbagh

Lou Ruvo Brain Institute

Peter Ring

Peter Ring

Technical University of Munich

Something went wrong. Please try again later.